Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study

Saved in:
Bibliographic Details
Published in:Clinical and translational medicine 2021-12, Vol.11 (12), p.e584-n/a
Main Authors: Zhang, Mu‐Chen, Fang, Ying, Xu, Peng‐Peng, Dong, Lei, Shen, Rong, Huang, Yao‐Hui, Fu, Di, Yan, Zi‐Xun, Cheng, Shu, Jiang, Xu‐Feng, Song, Qi, He, Yang, Zhao, Yan, Lu, Min, Ye, Jing, Liu, Feng, Cheng, Lin, Wang, Chao‐Fu, Wang, Li, Zhao, Wei‐Li
Format: Article
Language:English
Subjects:
Aged
Biomarkers
Biomarkers - analysis
Cancer
Cell cycle
Decitabine - metabolism
Decitabine - pharmacology
DNA methylation
Female
Humans
Interferon
Letter to Editor
Lymphoma
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - genetics
Lymphoma, Large B-Cell, Diffuse - physiopathology
Male
Middle Aged
Multivariate analysis
Mutation
Remission (Medicine)
Treatment Outcome
Tumor Microenvironment - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3
cites cdi_FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3
container_end_page n/a
container_issue 12
container_start_page e584
container_title Clinical and translational medicine
container_volume 11
creator Zhang, Mu‐Chen
Fang, Ying
Xu, Peng‐Peng
Dong, Lei
Shen, Rong
Huang, Yao‐Hui
Fu, Di
Yan, Zi‐Xun
Cheng, Shu
Jiang, Xu‐Feng
Song, Qi
He, Yang
Zhao, Yan
Lu, Min
Ye, Jing
Liu, Feng
Cheng, Lin
Wang, Chao‐Fu
Wang, Li
Zhao, Wei‐Li
description
doi_str_mv 10.1002/ctm2.584
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3791042ffdfc4185a361eccc88ab8e5f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3791042ffdfc4185a361eccc88ab8e5f</doaj_id><sourcerecordid>3115250278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEotVSiSdAlrhwSes_SZzlgAQroJWKWqFythx7vOvFsRc76So3HoF34Y14ErzdUlokfLCtmc8_f5qZonhO8DHBmJ6ooafHdVs9Kg4pxqQkjDaP790PiqOU1jivtprPOX1aHLBqThlv8GHxc-Gst0o6BMbkU01Ieo2GsQ9jRL1VMYC_tjH4HvyArDduBK8ABYM0KDvIznpAGzcm9PnX9x-L04vLrEIbOdj8IKGtHVbIw9ZNSFu59CGBzjdjxgTIybgE9G73DpxDbuo3q9DL1-hyJXOanNAbN53NwfgVIkrDqKdnxRMjXYKj23NWfPnw_mpxWp5ffDxbvD0vVY1JVSrNOOMUNDBaA6UNlQ2veJdtk07lTN2QWrdQdx1IbmreGDavsGbKKMAY2Kw423N1kGuxiTabmESQVtwEQlwKGQerHAjG5wRX1BhtVEXaWrKGgFKqbWWXfzCZ9WbP2oxdD1rl2kTpHkAfZrxdiWW4Fm3TVpzUGfDqFhDDtxHSIHqbVK6a9BDGJGhDKGYVz9usePmPdJ2b6XOpBCOkpjWmvP0LzC1OKYK5M0Ow2A2W2A2WyIOVpS_um78T_hmjLCj3gq11MP0XJBZXn-gO-Bsiq9wx</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3115250278</pqid></control><display><type>article</type><title>Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Zhang, Mu‐Chen ; Fang, Ying ; Xu, Peng‐Peng ; Dong, Lei ; Shen, Rong ; Huang, Yao‐Hui ; Fu, Di ; Yan, Zi‐Xun ; Cheng, Shu ; Jiang, Xu‐Feng ; Song, Qi ; He, Yang ; Zhao, Yan ; Lu, Min ; Ye, Jing ; Liu, Feng ; Cheng, Lin ; Wang, Chao‐Fu ; Wang, Li ; Zhao, Wei‐Li</creator><creatorcontrib>Zhang, Mu‐Chen ; Fang, Ying ; Xu, Peng‐Peng ; Dong, Lei ; Shen, Rong ; Huang, Yao‐Hui ; Fu, Di ; Yan, Zi‐Xun ; Cheng, Shu ; Jiang, Xu‐Feng ; Song, Qi ; He, Yang ; Zhao, Yan ; Lu, Min ; Ye, Jing ; Liu, Feng ; Cheng, Lin ; Wang, Chao‐Fu ; Wang, Li ; Zhao, Wei‐Li</creatorcontrib><identifier>ISSN: 2001-1326</identifier><identifier>EISSN: 2001-1326</identifier><identifier>DOI: 10.1002/ctm2.584</identifier><identifier>PMID: 34923760</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Aged ; Biomarkers ; Biomarkers - analysis ; Cancer ; Cell cycle ; Decitabine - metabolism ; Decitabine - pharmacology ; DNA methylation ; Female ; Humans ; Interferon ; Letter to Editor ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - diagnosis ; Lymphoma, Large B-Cell, Diffuse - genetics ; Lymphoma, Large B-Cell, Diffuse - physiopathology ; Male ; Middle Aged ; Multivariate analysis ; Mutation ; Remission (Medicine) ; Treatment Outcome ; Tumor Microenvironment - physiology</subject><ispartof>Clinical and translational medicine, 2021-12, Vol.11 (12), p.e584-n/a</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3</citedby><cites>FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3</cites><orcidid>0000-0002-6834-1616</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3115250278/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3115250278?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34923760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Mu‐Chen</creatorcontrib><creatorcontrib>Fang, Ying</creatorcontrib><creatorcontrib>Xu, Peng‐Peng</creatorcontrib><creatorcontrib>Dong, Lei</creatorcontrib><creatorcontrib>Shen, Rong</creatorcontrib><creatorcontrib>Huang, Yao‐Hui</creatorcontrib><creatorcontrib>Fu, Di</creatorcontrib><creatorcontrib>Yan, Zi‐Xun</creatorcontrib><creatorcontrib>Cheng, Shu</creatorcontrib><creatorcontrib>Jiang, Xu‐Feng</creatorcontrib><creatorcontrib>Song, Qi</creatorcontrib><creatorcontrib>He, Yang</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><creatorcontrib>Lu, Min</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Liu, Feng</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Wang, Chao‐Fu</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Zhao, Wei‐Li</creatorcontrib><title>Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study</title><title>Clinical and translational medicine</title><addtitle>Clin Transl Med</addtitle><subject>Aged</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Decitabine - metabolism</subject><subject>Decitabine - pharmacology</subject><subject>DNA methylation</subject><subject>Female</subject><subject>Humans</subject><subject>Interferon</subject><subject>Letter to Editor</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - diagnosis</subject><subject>Lymphoma, Large B-Cell, Diffuse - genetics</subject><subject>Lymphoma, Large B-Cell, Diffuse - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Mutation</subject><subject>Remission (Medicine)</subject><subject>Treatment Outcome</subject><subject>Tumor Microenvironment - physiology</subject><issn>2001-1326</issn><issn>2001-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks9u1DAQxiMEotVSiSdAlrhwSes_SZzlgAQroJWKWqFythx7vOvFsRc76So3HoF34Y14ErzdUlokfLCtmc8_f5qZonhO8DHBmJ6ooafHdVs9Kg4pxqQkjDaP790PiqOU1jivtprPOX1aHLBqThlv8GHxc-Gst0o6BMbkU01Ieo2GsQ9jRL1VMYC_tjH4HvyArDduBK8ABYM0KDvIznpAGzcm9PnX9x-L04vLrEIbOdj8IKGtHVbIw9ZNSFu59CGBzjdjxgTIybgE9G73DpxDbuo3q9DL1-hyJXOanNAbN53NwfgVIkrDqKdnxRMjXYKj23NWfPnw_mpxWp5ffDxbvD0vVY1JVSrNOOMUNDBaA6UNlQ2veJdtk07lTN2QWrdQdx1IbmreGDavsGbKKMAY2Kw423N1kGuxiTabmESQVtwEQlwKGQerHAjG5wRX1BhtVEXaWrKGgFKqbWWXfzCZ9WbP2oxdD1rl2kTpHkAfZrxdiWW4Fm3TVpzUGfDqFhDDtxHSIHqbVK6a9BDGJGhDKGYVz9usePmPdJ2b6XOpBCOkpjWmvP0LzC1OKYK5M0Ow2A2W2A2WyIOVpS_um78T_hmjLCj3gq11MP0XJBZXn-gO-Bsiq9wx</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Zhang, Mu‐Chen</creator><creator>Fang, Ying</creator><creator>Xu, Peng‐Peng</creator><creator>Dong, Lei</creator><creator>Shen, Rong</creator><creator>Huang, Yao‐Hui</creator><creator>Fu, Di</creator><creator>Yan, Zi‐Xun</creator><creator>Cheng, Shu</creator><creator>Jiang, Xu‐Feng</creator><creator>Song, Qi</creator><creator>He, Yang</creator><creator>Zhao, Yan</creator><creator>Lu, Min</creator><creator>Ye, Jing</creator><creator>Liu, Feng</creator><creator>Cheng, Lin</creator><creator>Wang, Chao‐Fu</creator><creator>Wang, Li</creator><creator>Zhao, Wei‐Li</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6834-1616</orcidid></search><sort><creationdate>202112</creationdate><title>Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study</title><author>Zhang, Mu‐Chen ; Fang, Ying ; Xu, Peng‐Peng ; Dong, Lei ; Shen, Rong ; Huang, Yao‐Hui ; Fu, Di ; Yan, Zi‐Xun ; Cheng, Shu ; Jiang, Xu‐Feng ; Song, Qi ; He, Yang ; Zhao, Yan ; Lu, Min ; Ye, Jing ; Liu, Feng ; Cheng, Lin ; Wang, Chao‐Fu ; Wang, Li ; Zhao, Wei‐Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Decitabine - metabolism</topic><topic>Decitabine - pharmacology</topic><topic>DNA methylation</topic><topic>Female</topic><topic>Humans</topic><topic>Interferon</topic><topic>Letter to Editor</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - diagnosis</topic><topic>Lymphoma, Large B-Cell, Diffuse - genetics</topic><topic>Lymphoma, Large B-Cell, Diffuse - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Mutation</topic><topic>Remission (Medicine)</topic><topic>Treatment Outcome</topic><topic>Tumor Microenvironment - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Mu‐Chen</creatorcontrib><creatorcontrib>Fang, Ying</creatorcontrib><creatorcontrib>Xu, Peng‐Peng</creatorcontrib><creatorcontrib>Dong, Lei</creatorcontrib><creatorcontrib>Shen, Rong</creatorcontrib><creatorcontrib>Huang, Yao‐Hui</creatorcontrib><creatorcontrib>Fu, Di</creatorcontrib><creatorcontrib>Yan, Zi‐Xun</creatorcontrib><creatorcontrib>Cheng, Shu</creatorcontrib><creatorcontrib>Jiang, Xu‐Feng</creatorcontrib><creatorcontrib>Song, Qi</creatorcontrib><creatorcontrib>He, Yang</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><creatorcontrib>Lu, Min</creatorcontrib><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Liu, Feng</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Wang, Chao‐Fu</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Zhao, Wei‐Li</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Online Library Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical and translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Mu‐Chen</au><au>Fang, Ying</au><au>Xu, Peng‐Peng</au><au>Dong, Lei</au><au>Shen, Rong</au><au>Huang, Yao‐Hui</au><au>Fu, Di</au><au>Yan, Zi‐Xun</au><au>Cheng, Shu</au><au>Jiang, Xu‐Feng</au><au>Song, Qi</au><au>He, Yang</au><au>Zhao, Yan</au><au>Lu, Min</au><au>Ye, Jing</au><au>Liu, Feng</au><au>Cheng, Lin</au><au>Wang, Chao‐Fu</au><au>Wang, Li</au><au>Zhao, Wei‐Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study</atitle><jtitle>Clinical and translational medicine</jtitle><addtitle>Clin Transl Med</addtitle><date>2021-12</date><risdate>2021</risdate><volume>11</volume><issue>12</issue><spage>e584</spage><epage>n/a</epage><pages>e584-n/a</pages><issn>2001-1326</issn><eissn>2001-1326</eissn><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34923760</pmid><doi>10.1002/ctm2.584</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6834-1616</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2001-1326
ispartof Clinical and translational medicine, 2021-12, Vol.11 (12), p.e584-n/a
issn 2001-1326
2001-1326
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3791042ffdfc4185a361eccc88ab8e5f
source Publicly Available Content Database; Wiley Open Access; PubMed Central
subjects Aged
Biomarkers
Biomarkers - analysis
Cancer
Cell cycle
Decitabine - metabolism
Decitabine - pharmacology
DNA methylation
Female
Humans
Interferon
Letter to Editor
Lymphoma
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - genetics
Lymphoma, Large B-Cell, Diffuse - physiopathology
Male
Middle Aged
Multivariate analysis
Mutation
Remission (Medicine)
Treatment Outcome
Tumor Microenvironment - physiology
title Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A21%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20efficacy%20and%20tumour%20microenvironment%20influence%20of%20decitabine%20plus%20R%E2%80%90CHOP%20in%20patients%20with%20newly%20diagnosed%20diffuse%20large%20B%E2%80%90Cell%20lymphoma:%20Phase%201/2%20and%20biomarker%20study&rft.jtitle=Clinical%20and%20translational%20medicine&rft.au=Zhang,%20Mu%E2%80%90Chen&rft.date=2021-12&rft.volume=11&rft.issue=12&rft.spage=e584&rft.epage=n/a&rft.pages=e584-n/a&rft.issn=2001-1326&rft.eissn=2001-1326&rft_id=info:doi/10.1002/ctm2.584&rft_dat=%3Cproquest_doaj_%3E3115250278%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5014-cd37372ede325e2262a6747bdec1bc3725615d8e5bbea7f576f3940d3cfce00e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3115250278&rft_id=info:pmid/34923760&rfr_iscdi=true